Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Unii-xj83r4lq52
2. Comtifator (usan)
3. 2518151-57-8
4. Comtifator [usan]
5. 2-(4-chloro-3-fluorophenoxy)-n-((3s,6r)-6-(5-(2-(trifluoromethoxy)ethoxy)-1,3,4-oxadiazol-2-yl)piperidin-3-yl)acetamide
6. Acetamide, 2-(4-chloro-3-fluorophenoxy)-n-((3s,6r)-6-(5-(2-(trifluoromethoxy)ethoxy)-1,3,4-oxadiazol-2-yl)-3-piperidinyl)-
7. Comtifator
8. Comtifator [inn]
9. 2-(4-chloro-3-fluorophenoxy)-n-[(3s,6r)-6-{5-[2-(trifluoromethoxy)ethoxy]-1,3,4-oxadiazol-2-yl}piperidin-3-yl]acetamide
10. Acetamide, 2-(4-chloro-3-fluorophenoxy)-n-[(3s,6r)-6-[5-[2-(trifluoromethoxy)ethoxy]-1,3,4-oxadiazol-2-yl]-3-piperidinyl]-
11. Schembl22588621
12. Eoai4018683
13. Eoai-4018683
14. Bms-986419
15. Evt-4018683
16. Bms-986419-01
17. D13104
| Molecular Weight | 482.8 g/mol |
|---|---|
| Molecular Formula | C18H19ClF4N4O5 |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 9 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 108 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 608 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
69
PharmaCompass offers a list of BMS-986419 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right BMS-986419 manufacturer or BMS-986419 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred BMS-986419 manufacturer or BMS-986419 supplier.
A BMS-986419 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BMS-986419, including repackagers and relabelers. The FDA regulates BMS-986419 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BMS-986419 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A BMS-986419 supplier is an individual or a company that provides BMS-986419 active pharmaceutical ingredient (API) or BMS-986419 finished formulations upon request. The BMS-986419 suppliers may include BMS-986419 API manufacturers, exporters, distributors and traders.
BMS-986419 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of BMS-986419 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right BMS-986419 GMP manufacturer or BMS-986419 GMP API supplier for your needs.
A BMS-986419 CoA (Certificate of Analysis) is a formal document that attests to BMS-986419's compliance with BMS-986419 specifications and serves as a tool for batch-level quality control.
BMS-986419 CoA mostly includes findings from lab analyses of a specific batch. For each BMS-986419 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
BMS-986419 may be tested according to a variety of international standards, such as European Pharmacopoeia (BMS-986419 EP), BMS-986419 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (BMS-986419 USP).
